Cargando…
Injectable Hydrogels for Sustained Codelivery of Subunit Vaccines Enhance Humoral Immunity
[Image: see text] Vaccines aim to elicit a robust, yet targeted, immune response. Failure of a vaccine to elicit such a response arises in part from inappropriate temporal control over antigen and adjuvant presentation to the immune system. In this work, we sought to exploit the immune system’s natu...
Autores principales: | Roth, Gillie A., Gale, Emily C., Alcántara-Hernández, Marcela, Luo, Wei, Axpe, Eneko, Verma, Rohit, Yin, Qian, Yu, Anthony C., Lopez Hernandez, Hector, Maikawa, Caitlin L., Smith, Anton A. A., Davis, Mark M., Pulendran, Bali, Idoyaga, Juliana, Appel, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596866/ https://www.ncbi.nlm.nih.gov/pubmed/33145416 http://dx.doi.org/10.1021/acscentsci.0c00732 |
Ejemplares similares
-
Prolonged Codelivery of Hemagglutinin and a TLR7/8
Agonist in a Supramolecular Polymer–Nanoparticle Hydrogel Enhances
Potency and Breadth of Influenza Vaccination
por: Roth, Gillie A., et al.
Publicado: (2021) -
Modulation of injectable hydrogel properties for slow co‐delivery of influenza subunit vaccine components enhance the potency of humoral immunity
por: Saouaf, Olivia M., et al.
Publicado: (2021) -
A Multiscale Model for Solute Diffusion in Hydrogels
por: Axpe, Eneko, et al.
Publicado: (2019) -
Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2
por: Gale, Emily C., et al.
Publicado: (2021) -
Nanoparticles Presenting Potent TLR7/8 Agonists Enhance
Anti-PD-L1 Immunotherapy in Cancer Treatment
por: Smith, Anton A. A., et al.
Publicado: (2020)